Table 3.
Group | n | After treatment | Before treatment | ||||
---|---|---|---|---|---|---|---|
Platelet count (× 109 / L, SD) |
PT (S, SD) |
APTT (S, SD) |
Platelet count (×109 / L, SD) |
PT (S, SD) |
APTT (S, SD) |
||
Group 1 | 60 | 237.2 ± 52.2 | 11.2 ± 0.7 | 28.4 ± 3.4 | 227.6 ± 44.8* | 11.0 ± 0.6▲ | 28.0 ± 4.2△ |
Group 2 | 60 | 243.1 ± 43.5 | 11.3 ± 0.8 | 27.7 ± 3.6 | 241.5 ± 46.7* | 11.2 ± 0.8▲ | 27.4 ± 3.6△ |
Group 3 | 60 | 228.3 ± 39.2 | 11.4 ± 0.4 | 28.2 ± 3.3 | 235.7 ± 49.5* | 11.2 ± 0.7▲ | 28.3 ± 3.4△ |
F | – | 1.6 | 1.2 | 0.6 | 1.3 | 1.2 | 0.8 |
P | – | 0.2 | 0.2 | 0.5 | 0.2 | 0.3 | 0.4 |
* Compared with platelet count before treatment, P = n.s; ▲ Compared with PT before treatment, P = n.s; △ Compared with APTT before treatment, P = n.s; PT Prothrombin time, APTT Activated partial thromboplastin time, S Second, SD Standard deviation